Opinion: Tweeting to the Top

The lines between scholarly and traditional forms of popular communication are fading, and scientists need to take advantage.

Written bySara K. Yeo et al.
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, ANDREAS ELDHSocial media and Web 2.0 technologies are narrowing the communication divide between experts, journalists, and lay audiences. Not only can scientists communicate to lay audiences directly, they can interact with them. Given the rate at which modern technologies leave the lab and hit the marketplace, media outlets are extremely important for building public awareness around new breakthroughs in science and technology. Nanotechnology, for example, first caught the public’s collective eye through popular accounts in comic books, movies, and television series like Star Trek.

Despite the common assumption by scientists that public communication is rarely beneficial and may be detrimental—for example, by being too time consuming—there has been no empirical investigation into whether scientists’ efforts to communicate with wider audiences through social media are impactful for their careers.

In order to investigate this issue, we surveyed leading scientists involved in nanotechnology research at universities across the United States to ask them about their behaviors regarding lay communication, then tracked their academic impact using the h-index (PNAS, 102:16569-72, 2005), a measure that includes the number of peer-reviewed articles published and the number of citations accrued. Using survey data and data on scientists’ online activity that we collected in 2011 and 2012, we examined differences in h-indices among scientists who participated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies